Growth 250 rebounds, space ventures are STAR = Emerging Markets, 17th.
The TSE Growth Market 250 Index rebounded. Buying focused on major stocks resulted in a steady trend. Space ventures such as Synspective <290A.T>, ispace <9348.T>, and Astroscale Holdings <186A.T> are STAR. Plaid <4165.T> and Heartsseed <219A.T> also saw increases. Trial Holdings <141A.T> and AI Robotics <247A.T> are low. In the standard category.
Advanced Reading Strategy Command Room = Heart Seed: Attention on the promising heart failure treatment progress, also gaining attention at the World Expo.
The biotech company Heartseed <219A.T> is likely to draw attention at the Osaka-Kansai Expo. It has developed "HS-001," which treats heart failure by injecting and transplanting allogeneic iPS cell-derived cardiomyocytes into the affected area through an open-heart surgery, regenerating and strengthening the cells to cure heart failure. Currently, there are 10 cases undergoing clinical trials, with 5 cases at a low dose and 5 cases at a high dose. The next generation product, "HS-005," will implant cardiomyocytes into the affected area via catheter without open-heart surgery, reducing the burden on patients.
Growth 250 plummeted, with declines in SanBio ETC = Emerging Markets, September 9.
The Tokyo Stock Exchange Growth Market 250 Index has sharply declined. Due to concerns over a trade war, there is a tendency for stock prices to drop again, with Emerging Markets also experiencing widespread losses. Major stocks such as Cover <5253.T> and SanBio <4592.T> have fallen. The drops of Genda <9166.T> and iSpace <9348.T> were also noticeable. Qualips <4894.T> and Heartseed <219A.T> have increased. In the Standard sector, Harmonic Drive Systems <6324.T> has reached new lows.
CellSeed - temporarily reached the upper limit, with a rapid rise in Qualisys expanding interest in drug discovery-related stocks.
The stock reached a temporary high. Qualips <4894> announced its application for manufacturing and selling regenerative medicine products derived from iPS cell-derived cardiac muscle cell sheets, which has led to a surge in buying interest, reaching a stop-high buying indication, expanding into drug discovery-related stocks. Besides Cellseed, K Pharma <4896> and Heartseed <219A> are also rapidly rising. Cellseed disclosed the start of clinical trials for allogenic cartilage cell sheets on March 24, which seems to be attracting renewed buying interest.
Premium Stocks News = The theory of Prime Minister Ishiba's resignation is gaining strength, and attention is once again focused on "related to Takai."
The imposition of reciprocal tariffs announced by President Trump is shocking the world. There is a concern that it could significantly impact the Japanese economy, and the pressure on the Ishiba administration seems likely to intensify. Within the ruling Liberal Democratic Party, calls for the Prime Minister's resignation are being openly voiced, and there is potential for political expansion ahead of the House of Councillors elections in July. <Considering the diplomatic crisis and the House of Councillors elections> At a meeting held on the 3rd by the "Conservative Unity Association," composed of conservative members of the Liberal Democratic Party, demands for resignation were raised, stating "The Ishiba administration cannot win the House of Councillors elections."
The Growth 250 fell for four consecutive days, with continued Sell on major stocks in Emerging Markets on the 1st.
The Tokyo Stock Exchange Growth Market 250 Index has fallen for four consecutive days. Selling continues mainly among leading stocks. Companies such as Cover <5253.T>, BASE <4477.T>, and Heartspeed <219A.T> have seen declines. Due to worsening market conditions, there has been selling also on recently IPO'd stocks like Dynamic Map Platform <336A.T> and ZenmuTech <338A.T>. The Standard Market is also showing a weak trend. Provided by Wealth Advisor Co.
The Growth 250 has declined, with Heart Seed ETC falling in the Emerging Markets on the 27th.
The Tokyo Stock Exchange Growth Market 250 Index declined. In response to falling U.S. stocks, the entire Tokyo market experienced a downward trend, and Emerging Markets also followed this pattern. Taimi <215A.T>, Heartseed <219A.T>, and BASE <4477.T> were down, while TKP <3479.T> and ispace <9348.T> also saw declines. In the IPO (initial public offering) segment, there was a rush to Buy ZenmuTech <338A.T>. Provided by Wealth Advisor Co.
Premium Stock News = There are still stocks related to Takai, pay attention to the "National Dental Checkup for All Citizens."
Amid the issue of Prime Minister Ishiba distributing Commodity ETF vouchers to members of the National Diet, the related stocks of former Economic Security Minister Takai, seen as the strongest candidate for a post-Ishiba era, are surging due to speculative buying. A broader range of selections is also in sight. <Heart Seed is up 35%, along with Mark and others> Prime Minister Ishiba apologized for the distribution of the Commodity ETF vouchers but stated there is no illegality involved. However, the opposition parties are largely united in their stance that it violates regulatory laws and are preparing to pursue the matter. Calls questioning the Prime Minister's responsibility are also emerging within the ruling Liberal Democratic Party.
The Growth 250 continues to rise, with GENDA and others increasing = Emerging Markets, 17th.
The Tokyo Stock Exchange Growth Market 250 Index continues to rise. The Tokyo market shows strong movement in response to rising U.S. stocks, and the Growth 250 also maintains an upward trend. Cover <5253.T>, Heartseed <219A.T>, and GENDAL <9166.T> have increased, while Asiro <7378.T> and Ecomott <3987.T> saw significant gains. Timee <215A.T> experienced a decline. In the Standard segment, Maruchiyo Yamaoka <3399.T> was sold. Provided by Wealth Advisor Co.
Timy and other stocks that are interesting based on changes in Volume.
Stock closing price change Volume * <4316> Beamap 433801 445600 * <3930> Hatena 140215 7202300 * <1905> Tenox 116816 58900 * <2164> Regional Newspaper Company 388271 19100 * <7692> E-Infinity 115307 717800 * <9218> Mental Health T 788331 29700 * <4571> NANO MRNAs 159 15 1356500 * <219A> Heart S
Growth 250 rebounds, Heart Seed rises significantly = Emerging Markets, 14th.
The Tokyo Stock Exchange Growth Market 250 Index rebounded. Strong buying in leading stocks occurred in a robust weekend market. Heartspeed <219A.T> experienced a significant rise, while Trial Holdings <141A.T> and BASE <4477.T> also performed well. FFRI <3692.T> and Reiwa AH <296A.T> were also bought. In the standard market, Harmonic Drive Systems <6324.T> rebounded for the first time in six days. Provided by Wealth Advisor Co.
Token Corporation, 3Q operating profit increased by 97.8% to 16.6 billion yen.
The third quarter performance for the fiscal year ending April 2025 announced by Tokken Corporation (1766) showed a revenue of 271.146 billion yen, which is a 7.9% increase compared to the same period last year, and an operating profit of 16.666 billion yen, up 97.8% year-on-year. In the construction business, the increase in the order volume from the previous fiscal year has resulted in an increase in completed construction value compared to the same period last year. Although the prices of Construction Materials and labor costs continue to rise, properties that underwent price revisions in previous years have now been completed.
Attention points for PTS on the 13th = Canon Inc-Spons Adr, Tra's On, Timee, Neo Japan ETC.
▽Canon Inc-Spons Adr <7751.T> has set a buyback limit of 100 billion yen and 26 million shares (2.8% of the total issued stocks). ▽Trauson <6696.T> has resolved the notation of "important events concerning the premise of a continuing business". The digital signage platform "Celldis" has been adopted by 2,000 Docomo shops. ▽Timee <215A.T> has an operating profit of 1.41 billion yen for the first quarter of the fiscal year ending October 2025 (from November 2024 to January 2025). ▽NeoJapan.
Heartseed Inc. Reports Q1 2025 Financial Results With Strong Equity Ratio
Heartseed: Summary of financial results for the 1st quarter of the fiscal year ending 2025/12 [Japanese GAAP] (unconsolidated)
Learning conditions, GigWorks, Mirai Al, Hagiwara Industry (10th).
※The above Calendar is only a tentative schedule and may change due to the company's circumstances. --------------------------------------- March 10 (Monday) <1436> Green Energy <2301> Gakujou <2375> Gig Works <2991> Land Net <3180> B Garage <4238> Mirai Ar <4441> Tobira Systems <7623> Sun Autos <7682>
Heartseed Inc. Launches Analyst Report to Boost Investor Insights
Advance reading strategy command room = Heart Seed: Ideal Buy Round 2.
Heartsheed <219A.T> is expected to be a leading contender in cardiac cell regenerative Medical, but the stock price has returned to the level it started to soar in December 2024. However, the 5-day moving average has recently turned upwards, showing signs of a bottoming out. The leading cause of death worldwide is heart disease, with heart failure due to left ventricular dysfunction being the foremost. The company believes that implanting ventricular muscles selectively mass-produced from iPS cells could be a fundamental treatment for heart failure caused by contraction dysfunction.
The Tokyo Stock Exchange Growth Market Index has fallen for three consecutive days, showing general weakness similar to the main market.
Tokyo Stock Exchange Growth Market Index 827.06 -9.71 / Volume 0.1 billion 80.04 million shares / Trading value 109.5 billion yen Tokyo Stock Exchange Growth Market 250 Index 642.15 -8.52 / Volume 0.1 billion 6.29 million shares / Trading value 86.7 billion yen. Today in the growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index fell for three consecutive trading days. The number of rising stocks was 144, the number of falling stocks was 427, and those unchanged were 29. On January 31, in the USA market, the Dow Inc average declined by 337.47 dollars.
Heartseed Completes Patient Enrollment for HS-001 Clinical Trial